319 related articles for article (PubMed ID: 33905481)
1. Vaccinated and Convalescent Donor-Derived Severe Acute Respiratory Syndrome Coronavirus 2-Specific T Cells as Adoptive Immunotherapy for High-Risk Coronavirus Disease 2019 Patients.
Papayanni PG; Chasiotis D; Koukoulias K; Georgakopoulou A; Iatrou A; Gavriilaki E; Giannaki C; Bitzani M; Geka E; Tasioudis P; Chloros D; Fylaktou A; Kioumis I; Triantafyllidou M; Dimou-Besikli S; Karavalakis G; Boutou AK; Siotou E; Anagnostopoulos A; Papadopoulou A; Yannaki E
Clin Infect Dis; 2021 Dec; 73(11):2073-2082. PubMed ID: 33905481
[TBL] [Abstract][Full Text] [Related]
2. [A functional platform to monitor SARS-CoV-2-specific T cell responses in vaccinated individuals and COVID-19 recovered patients].
Manselle Cocco MN; Veigas F; Bach CA; Blidner AG; Cagnoni AJ; D'Alotto-Moreno T; Hockl PF; Mahmoud Y; Scheidegger MA; Sirino AB; Torres NI; Wiersba V; Rabinovich GA
Medicina (B Aires); 2021; 81(5):683-687. PubMed ID: 34633939
[TBL] [Abstract][Full Text] [Related]
3. Immunogenic T cell epitopes of SARS-CoV-2 are recognized by circulating memory and naïve CD8 T cells of unexposed individuals.
Quiros-Fernandez I; Poorebrahim M; Fakhr E; Cid-Arregui A
EBioMedicine; 2021 Oct; 72():103610. PubMed ID: 34627082
[TBL] [Abstract][Full Text] [Related]
4. Adoptive transfer of ex vivo expanded SARS-CoV-2-specific cytotoxic lymphocytes: A viable strategy for COVID-19 immunosuppressed patients?
Guerreiro M; Aguilar-Gallardo C; Montoro J; Francés-Gómez C; Latorre V; Luna I; Planelles D; Carrasco MP; Gómez MD; González-Barberá EM; Aguado C; Sempere A; Solves P; Gómez-Seguí I; Balaguer-Rosello A; Louro A; Perla A; Larrea L; Sanz J; Arbona C; de la Rubia J; Geller R; Sanz MÁ; Sanz G; Luis Piñana J
Transpl Infect Dis; 2021 Aug; 23(4):e13602. PubMed ID: 33728702
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2-specific T cell therapy for severe COVID-19: a randomized phase 1/2 trial.
Papadopoulou A; Karavalakis G; Papadopoulou E; Xochelli A; Bousiou Z; Vogiatzoglou A; Papayanni PG; Georgakopoulou A; Giannaki M; Stavridou F; Vallianou I; Kammenou M; Varsamoudi E; Papadimitriou V; Giannaki C; Sileli M; Stergiouda Z; Stefanou G; Kourlaba G; Gounelas G; Triantafyllidou M; Siotou E; Karaglani A; Zotou E; Chatzika G; Boukla A; Papalexandri A; Koutra MG; Apostolou D; Pitsiou G; Morfesis P; Doumas M; Karampatakis T; Kapravelos N; Bitzani M; Theodorakopoulou M; Serasli E; Georgolopoulos G; Sakellari I; Fylaktou A; Tryfon S; Anagnostopoulos A; Yannaki E
Nat Med; 2023 Aug; 29(8):2019-2029. PubMed ID: 37460756
[TBL] [Abstract][Full Text] [Related]
6. T-Cell Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 Measured by an Interferon-γ Release Assay Is Strongly Associated With Patient Outcomes in Vaccinated Persons Hospitalized With Delta or Omicron Variants.
Fernández-González M; Agulló V; García JA; Padilla S; García-Abellán J; de la Rica A; Mascarell P; Masiá M; Gutiérrez F
J Infect Dis; 2023 Nov; 228(9):1240-1252. PubMed ID: 37418551
[TBL] [Abstract][Full Text] [Related]
7. Cellular Immunity in COVID-19 Convalescents with PCR-Confirmed Infection but with Undetectable SARS-CoV-2-Specific IgG.
Schwarzkopf S; Krawczyk A; Knop D; Klump H; Heinold A; Heinemann FM; Thümmler L; Temme C; Breyer M; Witzke O; Dittmer U; Lenz V; Horn PA; Lindemann M
Emerg Infect Dis; 2021 Jan; 27(1):. PubMed ID: 33058753
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2-specific T cells generated for adoptive immunotherapy are capable of recognizing multiple SARS-CoV-2 variants.
Panikkar A; Lineburg KE; Raju J; Chew KY; Ambalathingal GR; Rehan S; Swaminathan S; Crooks P; Le Texier L; Beagley L; Best S; Solomon M; Matthews KK; Srihari S; Neller MA; Short KR; Khanna R; Smith C
PLoS Pathog; 2022 Feb; 18(2):e1010339. PubMed ID: 35157735
[TBL] [Abstract][Full Text] [Related]
9. Rapid GMP-Compliant Expansion of SARS-CoV-2-Specific T Cells From Convalescent Donors for Use as an Allogeneic Cell Therapy for COVID-19.
Cooper RS; Fraser AR; Smith L; Burgoyne P; Imlach SN; Jarvis LM; Turner DM; Zahra S; Turner ML; Campbell JDM
Front Immunol; 2020; 11():598402. PubMed ID: 33488592
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
Wei J; Zhao J; Han M; Meng F; Zhou J
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2-specific T cells are rapidly expanded for therapeutic use and target conserved regions of the membrane protein.
Keller MD; Harris KM; Jensen-Wachspress MA; Kankate VV; Lang H; Lazarski CA; Durkee-Shock J; Lee PH; Chaudhry K; Webber K; Datar A; Terpilowski M; Reynolds EK; Stevenson EM; Val S; Shancer Z; Zhang N; Ulrey R; Ekanem U; Stanojevic M; Geiger A; Liang H; Hoq F; Abraham AA; Hanley PJ; Cruz CR; Ferrer K; Dropulic L; Gangler K; Burbelo PD; Jones RB; Cohen JI; Bollard CM
Blood; 2020 Dec; 136(25):2905-2917. PubMed ID: 33331927
[TBL] [Abstract][Full Text] [Related]
12. Human and novel coronavirus infections in children: a review.
Rajapakse N; Dixit D
Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19.
Braun J; Loyal L; Frentsch M; Wendisch D; Georg P; Kurth F; Hippenstiel S; Dingeldey M; Kruse B; Fauchere F; Baysal E; Mangold M; Henze L; Lauster R; Mall MA; Beyer K; Röhmel J; Voigt S; Schmitz J; Miltenyi S; Demuth I; Müller MA; Hocke A; Witzenrath M; Suttorp N; Kern F; Reimer U; Wenschuh H; Drosten C; Corman VM; Giesecke-Thiel C; Sander LE; Thiel A
Nature; 2020 Nov; 587(7833):270-274. PubMed ID: 32726801
[TBL] [Abstract][Full Text] [Related]
14. Reactive T Cells in Convalescent COVID-19 Patients With Negative SARS-CoV-2 Antibody Serology.
Steiner S; Schwarz T; Corman VM; Sotzny F; Bauer S; Drosten C; Volk HD; Scheibenbogen C; Hanitsch LG
Front Immunol; 2021; 12():687449. PubMed ID: 34322120
[TBL] [Abstract][Full Text] [Related]
15. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
[TBL] [Abstract][Full Text] [Related]
16. Rapid Manufacturing of Highly Cytotoxic Clinical-Grade SARS-CoV-2-specific T Cell Products Covering SARS-CoV-2 and Its Variants for Adoptive T Cell Therapy.
Bonifacius A; Tischer-Zimmermann S; Santamorena MM; Mausberg P; Schenk J; Koch S; Barnstorf-Brandes J; Gödecke N; Martens J; Goudeva L; Verboom M; Wittig J; Maecker-Kolhoff B; Baurmann H; Clark C; Brauns O; Simon M; Lang P; Cornely OA; Hallek M; Blasczyk R; Seiferling D; Köhler P; Eiz-Vesper B
Front Bioeng Biotechnol; 2022; 10():867042. PubMed ID: 35480981
[No Abstract] [Full Text] [Related]
17. Enhanced SARS-CoV-2-Specific CD4
Pavan Kumar N; Moideen K; Nancy A; Selvaraj N; Renji RM; Munisankar S; Thangaraj JWV; Muthusamy SK; Kumar CPG; Bhatnagar T; Ponnaiah M; Ramasamy S; Velusamy S; Murhekar MV; Babu S
Viruses; 2022 Mar; 14(3):. PubMed ID: 35336918
[TBL] [Abstract][Full Text] [Related]
18. Generation of glucocorticoid-resistant SARS-CoV-2 T cells for adoptive cell therapy.
Basar R; Uprety N; Ensley E; Daher M; Klein K; Martinez F; Aung F; Shanley M; Hu B; Gokdemir E; Nunez Cortes AK; Mendt M; Reyes Silva F; Acharya S; Laskowski T; Muniz-Feliciano L; Banerjee PP; Li Y; Li S; Melo Garcia L; Lin P; Shaim H; Yates SG; Marin D; Kaur I; Rao S; Mak D; Lin A; Miao Q; Dou J; Chen K; Champlin RE; Shpall EJ; Rezvani K
Cell Rep; 2021 Jul; 36(3):109432. PubMed ID: 34270918
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls.
Le Bert N; Tan AT; Kunasegaran K; Tham CYL; Hafezi M; Chia A; Chng MHY; Lin M; Tan N; Linster M; Chia WN; Chen MI; Wang LF; Ooi EE; Kalimuddin S; Tambyah PA; Low JG; Tan YJ; Bertoletti A
Nature; 2020 Aug; 584(7821):457-462. PubMed ID: 32668444
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjects.
Achiron A; Gurevich M; Falb R; Dreyer-Alster S; Sonis P; Mandel M
Clin Microbiol Infect; 2021 Sep; 27(9):1349.e1-1349.e6. PubMed ID: 33975009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
